Company profile
RenovaCare, Inc.
OTC: RCAR · Healthcare · Biotechnology
#1166 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 35
v0.1 · 5/100 weight · pillars only
↑ listing tenure, balance-sheet leverage · ↓ workforce scale, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$4.5M
Employees
1
as of 2026-08-30
Market cap
$8.7k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02021
Net income-$4.5M-$4.5M2021
Operating income-$5.4M-$5.4M2021
Total assets$3.7M$3.7M2021
Liabilities$1.3M$1.3M2021
Equity$2.3M$2.3M2021
Revenue trend
FY2014 – FY2021 · USD
FY14
FY15
FY16
FY17
FY18
FY19
FY20
FY21
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is RenovaCare, Inc.’s revenue?
RenovaCare, Inc. booked $0 in FY2021 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
VIA Pharmaceuticals, Inc.——OneLife Technologies Corp.——Capital Group Holdings, Inc.——Ceres Ventures, Inc.——HTC Purenergy Inc.——SES Solar Inc.——Neighbors
Maricopa →Key facts
CEOHarmel Singh Rayat
SectorHealthcare
IndustryBiotechnology
HeadquartersScottsdale, AZ
ExchangeOTC: RCAR
Employees1
IPO date1996-05-30
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.